Triple-negative breast cancer (TNBC) is an aggressive BC subtype accounting for 10–20% of all BC cases and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.